COMMUNIQUÉS West-GlobeNewswire

Best NAD+ Supplements: GenuinePurity Liposomal NAD For Anti-Aging & Longevity - Tested & Reviewed

28/04/2025 - 18:14

Leading Edge Health Announces 2025’s Best NAD+ Booster: GenuinePurity Liposomal NMN — Boost NAD+ levels naturally. Support energy, healthy aging, glowing skin, and longevity with ultra-absorbable NMN. Feel the [...]

IBA SA – NOTIFICATION TRANSPARENCE

28/04/2025 - 18:15

(article 14, alinéa 1er de la loi du 2 mai 2007 relative à la publicité des participations importantes) Louvain-la-Neuve, Belgique, le 28 avril 2024, 18:00 Résumé de la notification IBA (Ion Beam Applications SA), le [...]

IBA – TRANSPARENCY NOTIFICATION

28/04/2025 - 18:15

(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings) Louvain-la-Neuve, Belgium, April 28 th , 2024 06:00 PM Summary of the notification IBA (Ion Beam Applications), the world’s leading [...]

Volume Pills Under Reviews: Does This Semen Volume Booster Pills Works? Top Sperm Enhancer

28/04/2025 - 18:22

Volume Pills are a natural male enhancement supplement that increases semen volume, improves erection quality, and boosts sexual performance. Made with 100% natural ingredients, these pills support better sexual health [...]

Grant of Warrants

28/04/2025 - 18:28

April 28, 2025 Announcement no. 14 Grant of Warrants Copenhagen, Denmark, April 28, 2025, (GLOBE NEWSWIRE) – The Board of Directors of BioPorto A/S (“BioPorto” or the “Company”) (CPH:BIOPOR) has today implemented the [...]

Best NAD+ Supplement for Anti Aging and Brain Health 2025 - Top NMN Supplements and NAD Booster Pills for Longevity

28/04/2025 - 18:33

Glasgow, United Kingdom, April 28, 2025 (GLOBE NEWSWIRE) -- Looking to stay sharp, energized, and youthful? NAD+ supplements have become the best solution for fighting aging, boosting brain health, and increasing [...]

Virbac : Communiqué de mise à disposition du Rapport Annuel au 31 décembre 2024

28/04/2025 - 19:00

Le Groupe annonce avoir mis à la disposition du public et déposé auprès de l’Autorité des marchés financiers son Rapport Annuel au format ESEF au 31 décembre 2024. Le rapport annuel est par ailleurs disponible dans sa [...]

Virbac : Public release of Virbac Annual Report at 31 December 2024

28/04/2025 - 19:00

The Group released and filed its 2024 Annual Report with the French “Autorité des marchés financiers”, at the ESEF Format. Additionally, the report is attached at the PDF format. The document is also available on the [...]

Virbac : Rapport Annuel Virbac au 31 décembre 2024 (ESEF)

28/04/2025 - 19:00

Veuillez trouver le Rapport Annuel du Groupe au format ESEF au 31 décembre 2024. Pièce jointe Rapport_Annuel_Virbac_2024_XBRL

Appili Therapeutics Announces New Patents Granted for Commercial Stage Asset LIKMEZ®™

28/04/2025 - 13:41

New patents provide additional composition of matter and methods of use claims, strengthening the protection for liquid oral taste-masked reformulation, LIKMEZ New subject matter listed in the U.S. Food and Drug [...]

Silo Pharma Expands Intellectual Property Portfolio with Patent Application for Exclusively Licensed Alzheimer’s Drug

28/04/2025 - 13:50

SARASOTA, FL, April 28, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today [...]

Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2025 Annual Meeting

28/04/2025 - 13:59

New data includes real-world analyses of VOQUEZNA-treated patients in the U.S. diagnosed with gastroesophageal reflux disease (GERD) FLORHAM PARK, N.J., April 28, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. ( [...]

IN8bio Unveils Promising New Data from Next Generation Gamma-Delta T Cell Engager (TCE) Platform at AACR 2025

28/04/2025 - 14:00

First gamma-delta (γδ) TCE to demonstrate significant γδ T cell expansion and activation, potentially offering an alternative to conventional CD3-based approaches without significant adverse events such as cytokine [...]

Calidi Biotherapeutics Announces IL15 Superagonist as First Payload to be Delivered by Systemic Antitumor Virotherapy Platform at AACR Annual Meeting

28/04/2025 - 14:00

SAN DIEGO, April 28, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today [...]

LifeMD Acquires Women’s Health Provider Optimal Human Health MD to Accelerate Entry into the Women’s Health Market

28/04/2025 - 14:00

Acquisition Establishes Clinical and Operational Foundation for LifeMD’s Comprehensive Women’s Health Offering, Launching Summer 2025 NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading [...]

MediWound to Present New EscharEx® Data at Leading Wound Care Conferences

28/04/2025 - 14:00

Presentations at WHS and SAWC to highlight EscharEx’s mechanism of action, preclinical advantages over SANTYL ® , and new data in treating VLUs and DFUs Findings reinforce the ongoing Phase III study in VLUs and support [...]

Quanta Therapeutics Presents Late-Breaking Data for QTX3544, an Oral G12V-Preferring Multi-KRAS Inhibitor, at AACR Annual Meeting 2025

28/04/2025 - 14:00

- Preclinical data demonstrates synergy of QTX3544 with EGFR inhibitors, broadly enhancing anti-tumor activity - - Data supports ongoing Phase 1 clinical trial for QTX3544 as monotherapy and in combination with [...]

Zentalis Pharmaceuticals Announces First Patient Dosed in DENALI Part 2 Clinical Trial of Azenosertib in Patients with Cyclin E1+ PROC

28/04/2025 - 14:00

Phase 2 registration-intent trial enrolling Part 2a dose confirmation arms Topline data from DENALI Part 2 anticipated by year end 2026 with the potential to support an accelerated approval, subject to FDA feedback SAN [...]

Bioventus to Report First Quarter of Fiscal Year 2025 Financial Results on May 6, 2025

28/04/2025 - 14:00

DURHAM, N.C., April 28, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”) , a global leader in innovations for active healing, today announced that it will report financial results for [...]